Sera Prognostics, Inc. (SERA) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -39417.3%, revenue growth 76.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $81000.00 |
| Revenue (TTM) | $0.0B |
| Net Margin | -39417.3% |
| Operating Margin (TTM) | -53282.9% |
| Revenue Growth (YoY) | 76.5% |
| EPS Growth (YoY) | 12.5% |
| FCF Growth (YoY) | 162.6% |
| Price / Book | 1.72 |
| Price / Sales | 1456.62 |
| FCF Yield | -25.8% |
| Altman Z-Score | -2.97 (distress) |
| Industry P/E (Healthcare Services) | 24.6 |
| Sector P/E (Healthcare) | 21.6 |
SERA overview · SERA earnings · SERA KPIs · SERA documents · SERA ownership · SERA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.